Defibrillators Market to Reach USD 21.54 Billion by 2028 as Emergency Cardiac Care Expands

The defibrillators market was valued at USD 12.65 billion in 2022 and is projected to reach USD 21.54 billion by 2028. The market is forecast to expand at 9.18% during 2023-2028, reflecting rising demand for devices used during cardiac emergencies across healthcare facilities, public locations, and home environments.

Market Overview and Growth Outlook

“The defibrillators market is expected to grow at a CAGR of 9.18% during 2023-2028.” Cardiovascular diseases, including cardiac arrest and arrhythmias, are identified as an important demand driver. Defibrillators maintain normal heart rhythms during critical situations, supporting their role across emergency response, intensive care, operating rooms, public spaces, and private homes.

Technology development is another structural contributor to the industry outlook. Automated external defibrillators have become easier for non-medical professionals to use during emergency scenarios. At the same time, public awareness campaigns and training initiatives are increasing recognition of early defibrillation, strengthening the role of accessible devices in responding promptly to sudden cardiac arrest.

Analysis of defibrillators market trends highlights a market shaped by technology development, increasing healthcare access, public-awareness initiatives, and wider device availability. Government recognition of defibrillation during cardiac emergencies has also supported installations across public spaces, schools, and workplaces, while accessibility is expanding across airports, retail centers, sporting venues, and transit hubs.

Request a free sample report:

https://www.stratviewresearch.com/Request-Sample/defibrillators-market#form

Market Segmentation Analysis

By Type, the market is segmented into Implantable Cardioverter Defibrillators and External Defibrillators. Implantable Cardioverter Defibrillators held more than 65% of the market in 2022, while External Defibrillators are projected to record the fastest CAGR of nearly 9.2%. Technologically enhanced devices, longer lifespans, implant procedures, CRT-D adoption, and S-ICD systems support segment development.

By End-User Type, the categories are Hospitals, Clinics, and Cardiac Centers; Prehospital Care Settings Public Access Markets; Alternate Care Facilities; and Home Care Settings. Hospitals, clinics, and cardiac centers captured the largest market share in 2022, with hospitals accounting for more than 75%. The public access market segment is projected to register a CAGR of nearly 9.5%.

By Region, the segmentation is North America (Country Analysis: the USA, Canada, and Mexico); Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe); Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific); and Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others).

Regional Market Insights

North America held more than 30% of the market in 2022 and is expected to maintain its dominant position during the forecast period. The source identifies an increasing geriatric population, growing incidence of cardiac diseases, and technological advancements as important factors supporting regional defibrillator demand and reinforcing North America's position within the global market.

Asia-Pacific and Europe are also expected to offer substantial growth opportunities during the forecast period. The source page does not identify either region as the fastest-growing market or provide separate regional growth rates. Accordingly, the regional analysis supports North America as the dominant market while identifying Asia-Pacific and Europe as additional areas offering growth opportunities.

Emerging Trends Shaping the Defibrillators Market

Technology development is influencing how defibrillators are designed and used. Easier operation of automated external defibrillators is enabling non-medical professionals to use these devices during emergencies. Within implantable devices, technologically enhanced products with extended lifespans, increasing implant procedures, and adoption of CRT-Ds and S-ICD systems are contributing to market development.

Public accessibility represents another important industry trend. Defibrillators are increasingly intended for public locations, including airports, retail centers, sporting venues, and transit hubs. Awareness campaigns and training initiatives are reinforcing the importance of early defibrillation, while mandates in several countries support installations in public spaces, schools, and workplaces.

Key Growth Drivers of the Market

Cardiovascular diseases, including cardiac arrest and arrhythmias, sustain demand because defibrillators are vital tools used to restore normal heart rhythms during life-threatening cardiac emergencies.
Defibrillator technology development supports adoption by making automated external defibrillators easier for non-medical professionals to operate during emergency situations.
Public awareness campaigns and training initiatives emphasize early defibrillation, increasing recognition of rapid intervention during the first minutes following cardiac arrest.
Government mandates in several countries support installations in public spaces, schools, and workplaces, expanding the availability of defibrillation equipment outside traditional healthcare settings.
Increasing healthcare expenditure and improving healthcare infrastructure, particularly in developing nations, expand access to medical treatment and strengthen demand across hospitals, clinics, and ambulatory care centers.

Competitive Landscape

Top Companies in the Market

Biotronik

Boston Scientific

CU Medical Systems, Inc.

Koninklijke Philips N.V.

Mediana

Medtronic plc

Metsis Medikal

Microport

Mindray Medical

Nihon Kohden

Conclusion and Strategic Outlook

The defibrillators market is projected to advance from USD 12.65 billion in 2022 to USD 21.54 billion by 2028, registering a CAGR of 9.18% during 2023-2028. Market momentum reflects cardiovascular disease prevalence, technological development, greater public awareness, government-supported installations, improving healthcare infrastructure, and broader accessibility of defibrillators in public environments.

The market outlook also reflects distinct product and end-user dynamics. Implantable Cardioverter Defibrillators retained the larger type share in 2022, while External Defibrillators show the faster stated growth rate. Hospitals remain the leading end-user setting, while public access markets show strong forecast growth, highlighting the expanding reach of defibrillation beyond conventional clinical environments.

FAQs – Defibrillators Market

1. What is the size and forecast of the defibrillators market?

The defibrillators market was estimated at USD 12.65 billion in 2022. It is projected to reach USD 21.54 billion by 2028.

2. What is the expected CAGR of the defibrillators market?

The defibrillators market is expected to grow at a CAGR of 9.18% during 2023-2028. This rate defines the published market forecast period.

3. What factors are driving defibrillators market growth?

Key drivers include cardiovascular diseases, technological development, public awareness and training, government-supported public installations, increasing healthcare expenditure, and improving healthcare infrastructure. These factors expand demand and accessibility across clinical and public environments.

4. Which region leads the defibrillators market?

North America held more than 30% of the market in 2022 and is expected to maintain its dominance during the forecast period. Increasing geriatric population, cardiac disease incidence, and technological advancements support regional demand.

5. What does the investment outlook indicate about market risks and opportunities?

The source identifies growth drivers and opportunities rather than specific investment risks. Its market intelligence points to technological development, public access, healthcare infrastructure, and expanding device availability as factors shaping the 2023-2028 outlook.